187 results on '"Morani, Giovanni"'
Search Results
2. Prognostic significance of remotely monitored nocturnal heart rate in heart failure patients with reduced ejection fraction
3. Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors
4. Chronic venous obstruction during cardiac device revision: Incidence, predictors, and efficacy of percutaneous techniques to overcome the stenosis
5. Correlation between epicardial adipose tissue and atrial fibrillation burden in coronary artery bypass graft surgery
6. A curious ST-segment elevation case in a young man: a challenging diagnosis
7. Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation
8. Safety and efficacy of a cardiologist-only approach to deep sedation for electrical cardioversion
9. The Interplay of PR Interval and AV Pacing Delays Used for Cardiac Resynchronization Therapy in Heart Failure Patients: Association with Clinical Response in a Retrospective Analysis of a Large Observational Study
10. A case of removal of a “dancing” Micra
11. Pitfalls in electrogram interpretation: Subcutaneous cardioverter defibrillator malfunction in Brugada syndrome
12. Economic impact of remote monitoring after implantable defibrillators implantation in heart failure patients: an analysis from the EFFECT study
13. The lost superior vena cava: advancement in leadless pacemaker usability
14. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular cardiomyopathy: the course of electronic parameters, clinical features, and complications during long-term follow-up
15. The Impact of COVID-19 Pandemic and Lockdown Restrictions on Cardiac Implantable Device Recipients with Remote Monitoring
16. Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor?
17. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer
18. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial
19. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators
20. Role of Provocable Brugada ECG Pattern in The Correct Risk Stratification for Major Arrhythmic Events
21. Leadless pacemaker through tricuspid bioprosthetic valve: Early experience
22. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry
23. Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads
24. Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor?
25. Impact of body mass index on short-term outcome after acute myocardial infarction: Does excess body weight have a paradoxical protective role?
26. Leadless pacemaker twins in an achondroplastic dwarf
27. Clinical and economic impact of multipoint left ventricular pacing: A comparative analysis from the Italian registry on multipoint pacing in cardiac resynchronization therapy (IRON‐MPP)
28. General anaesthesia for external electrical cardioversion of atrial fibrillation: experience of an exclusively cardiological procedural management
29. Impact of multipoint pacing on projected battery longevity in cardiac resynchronization therapy. An IRON‐MPP study sub‐analysis
30. Prolonged sustained ventricular fibrillation in a patient with dextrocardia and a left ventricular assist device
31. Outpatient Electrical Cardioversion of Atrial Fibrillation: 8 Yearsʼ Experience. Analysis of Shock-Related Arrhythmias
32. Prediction of mortality in patients with implantable defibrillator using CHADS2 score: data from a prospective observational investigation
33. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy:Positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations
34. Troubleshooting in PM Leadless: How to manage an indissoluble knot
35. Effect of lead design and pacing vector on electrical parameters of quadripolar coronary sinus leads: The RALLY‐X4 study
36. Redo procedures and chronic renal dysfunction are associated with higher risk of cardiac electronic device infections
37. Subaxillary approach to cardiac electronic device implantation using a single surgical incision: a single-centre experience
38. Leadless pacemaker implantation in achondroplastic dwarfism and recurrent cardiac implantable electronic device infections: a case report
39. Patients with right bundle branch block and concomitant delayed left ventricular activation respond to cardiac resynchronization therapy
40. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations
41. Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes
42. Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
43. ICD shocks in few days in a patient with dilated cardiomyopathy with improved ejection fraction.
44. The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives
45. Patients with right bundle branch block and concomitant delayed left ventricular activation respond to cardiac resynchronization therapy.
46. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
47. Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study
48. 89-07: Multipoint pacing via a quadripolar left ventricular lead: Preliminary results from an Italian Registry
49. 136-63: Performance of straight and spiral multipolar coronary sinus leads : preliminary results of the RALLY-X4 study
50. 216-63: The economic impact of longevity of implantable cardioverter-defibrillator for cardiac resynchronization therapy from a healthcare service perspective
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.